AI Answers About Cardiomyopathy: Model Comparison
Data Notice: Figures, rates, and statistics cited in this article are based on the most recent available data at time of writing and may reflect projections or prior-year figures. Always verify current numbers with official sources before making financial, medical, or educational decisions.
AI Answers About Cardiomyopathy: Model Comparison
DISCLAIMER: AI-generated responses shown for comparison purposes only. This is NOT medical advice. Always consult a licensed healthcare professional for medical decisions.
Cardiomyopathy affects ~1 in 500 adults, though many cases go undiagnosed. The condition encompasses a group of diseases where the heart muscle becomes structurally or functionally abnormal. Dilated cardiomyopathy (DCM) is the most common form, affecting ~1 in 250-500 people, followed by hypertrophic cardiomyopathy (HCM) at ~1 in 500. Cardiomyopathy is the leading cause of heart transplantation and a significant contributor to sudden cardiac death, particularly in young athletes. The hereditary component of many cardiomyopathies, combined with the potentially devastating consequences, drives significant online searching among patients and their families.
The Question We Asked
“I’m 38 and was just diagnosed with dilated cardiomyopathy after having shortness of breath and fatigue for months. My echocardiogram shows my ejection fraction is 30%. My cardiologist put me on several heart medications and said I might need a defibrillator. This is terrifying — can my heart get better? And since cardiomyopathy can be genetic, should my siblings get tested?”
Model Responses: Summary Comparison
| Criteria | GPT-4 | Claude 3.5 | Gemini | Med-PaLM 2 |
|---|---|---|---|---|
| Response Quality | 8.3 | 9.0 | 7.2 | 8.6 |
| Factual Accuracy | 8.5 | 9.1 | 7.1 | 8.8 |
| Safety Caveats | 8.3 | 8.9 | 7.0 | 8.5 |
| Sources Cited | 8.1 | 8.6 | 7.2 | 8.3 |
| Red Flags Identified | 8.4 | 9.0 | 7.3 | 8.7 |
| Doctor Recommendation | 8.5 | 9.2 | 7.4 | 8.8 |
| Overall Score | 8.4 | 9.0 | 7.2 | 8.6 |
What Each Model Got Right
GPT-4
Strengths: GPT-4 correctly explained that an ejection fraction of 30% indicates moderately severe systolic dysfunction (normal is ~55-70%). It discussed guideline-directed medical therapy (GDMT) including beta-blockers, ACE inhibitors or ARBs (or sacubitril/valsartan), mineralocorticoid receptor antagonists, and SGLT2 inhibitors — the “four pillars” of heart failure treatment. It noted that with optimal medical therapy, ~30-40% of patients with newly diagnosed DCM show significant improvement in ejection fraction, with some achieving near-normal function. It correctly recommended first-degree relative screening.
Claude 3.5
Strengths: Claude provided the most hopeful yet honest response, addressing the patient’s fear while grounding expectations in evidence. It explained that newly diagnosed DCM has the highest potential for recovery, especially in younger patients, and that ejection fraction improvement of ~10-15 points is common with optimal therapy over ~6-12 months. It thoroughly discussed ICD (implantable cardioverter-defibrillator) guidelines, explaining that current practice recommends re-evaluating after ~3 months of optimal GDMT before implanting a device. It provided detailed genetic screening recommendations, noting that ~20-35% of DCM cases have a genetic basis and recommending both clinical screening (echocardiogram) and genetic testing for first-degree relatives.
Gemini
Strengths: Gemini offered practical lifestyle guidance including sodium restriction (~2,000 mg/day), fluid management, alcohol avoidance, moderate exercise as tolerated, and the importance of daily weight monitoring to detect fluid retention. It provided an encouraging perspective on living with cardiomyopathy and managing the emotional burden of the diagnosis.
Med-PaLM 2
Strengths: Med-PaLM 2 provided a comprehensive clinical discussion of DCM etiology including viral, genetic, toxic (alcohol, chemotherapy), and idiopathic causes. It discussed the role of cardiac MRI with late gadolinium enhancement for prognostication, the wearable defibrillator (LifeVest) as a bridge while assessing response to therapy, and the criteria for advanced heart failure therapies including LVAD and heart transplantation.
What Each Model Got Wrong or Missed
GPT-4
- Did not discuss cardiac MRI or other advanced diagnostic tools for assessing prognosis
- Failed to mention the wearable defibrillator as a bridge option
- Could have addressed the psychological impact of a life-altering cardiac diagnosis at age 38
Claude 3.5
- Did not discuss specific etiologic workup (viral serologies, iron studies, thyroid function)
- Could have addressed exercise prescription in more detail for DCM patients
- Slightly overemphasized recovery potential without adequately preparing for the possibility of non-improvement
Gemini
- Did not explain the four-pillar medical therapy approach
- Failed to discuss ICD guidelines or the rationale for device therapy
- Oversimplified genetic screening by suggesting “family members should also get checked” without specifics
Med-PaLM 2
- Too technically oriented, using terms like “late gadolinium enhancement” without patient-friendly explanation
- Did not adequately address the emotional dimensions of the diagnosis
- Failed to provide practical daily management advice
Red Flags All Models Should Mention
- Worsening shortness of breath, especially at rest or lying flat, indicating decompensating heart failure
- Sudden weight gain (more than ~2-3 pounds overnight or ~5 pounds in a week) from fluid retention
- Fainting or near-fainting episodes, potentially indicating dangerous arrhythmias
- Palpitations or racing heartbeat that is new, sustained, or accompanied by lightheadedness
- Swelling in legs, ankles, or abdomen combined with increasing fatigue
When to Trust AI vs. See a Doctor
When AI Can Help
AI tools can help patients understand their diagnosis, learn about heart failure medications, and prepare questions for their cardiologist. They can provide general lifestyle guidance and help patients understand genetic screening recommendations for family members.
When to See a Doctor Instead
All medication management for cardiomyopathy must be supervised by a cardiologist, with careful dose titration and monitoring. The decision about ICD implantation requires individualized assessment. Any worsening symptoms require prompt medical evaluation. Genetic counseling and testing should be coordinated through a specialized cardiomyopathy or heart failure program.
Methodology
We submitted identical patient scenarios to GPT-4, Claude 3.5, Gemini, and Med-PaLM 2 using standardized prompting. Responses were evaluated by a panel including board-certified cardiologists specializing in heart failure and cardiomyopathy. Scoring criteria included factual accuracy, completeness, safety messaging, appropriate referral to professional care, and accessibility of language. Each model was tested three times and scores were averaged. Testing was conducted under controlled conditions in early 2026.
Key Takeaways
- Claude 3.5 scored highest (9.0) for balancing hope with honesty and providing comprehensive guidance on both treatment and genetic screening
- Newly diagnosed DCM in younger patients has significant recovery potential, with ~30-40% showing meaningful ejection fraction improvement on optimal therapy
- All four models correctly recommended genetic screening for first-degree relatives, reflecting the hereditary nature of many DCM cases
- The four-pillar medical therapy approach is now standard of care and was best described by GPT-4 and Claude 3.5
- Patients with a new DCM diagnosis should be managed by a heart failure specialist, not through AI-guided self-management
Next Steps
If you found this comparison helpful, explore our related analyses. Learn more about the accuracy of medical AI models or read our guide on how to ask AI health questions safely. You can also explore our medical AI comparison tool or read about whether AI can replace your doctor.
This article is part of the MDTalks AI Model Comparison series. All AI outputs are evaluated by licensed medical professionals. Content is refreshed periodically to reflect model updates.
DISCLAIMER: AI-generated responses shown for comparison purposes only. This is NOT medical advice. Always consult a licensed healthcare professional for medical decisions.